[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,212,953
  • Shares Outstanding, K 51,659
  • Annual Sales, $ 379,810 K
  • Annual Income, $ -21,350 K
  • EBIT $ -16 M
  • EBITDA $ 5 M
  • 60-Month Beta 2.49
  • Price/Sales 3.16
  • Price/Cash Flow 3,569.56
  • Price/Book 3.83

Options Overview Details

View History
  • Implied Volatility 84.43% (+12.51%)
  • Historical Volatility 40.34%
  • IV Percentile 29%
  • IV Rank 23.66%
  • IV High 224.22% on 03/10/26
  • IV Low 41.09% on 05/14/26
  • Expected Move (DTE 29) 0.88 (3.53%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 196
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 866
  • Open Int (30-Day) 661
  • Expected Range 23.92 to 25.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.06
  • Number of Estimates 1
  • High Estimate $0.06
  • Low Estimate $0.06
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) +137.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.01 +23.61%
on 05/19/26
24.96 -0.90%
on 06/18/26
+4.15 (+20.13%)
since 05/18/26
3-Month
15.56 +58.97%
on 04/10/26
24.96 -0.90%
on 06/18/26
+7.36 (+42.32%)
since 03/18/26
52-Week
10.96 +125.68%
on 07/17/25
24.96 -0.90%
on 06/18/26
+5.70 (+29.98%)
since 06/18/25

Most Recent Stories

More News
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

Growing body of evidence supports AlloSure ® as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes Data across...

CDNA : 24.51 (+4.39%)
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology

AlloSure ® Kidney elevations are associated with increased risk of graft dysfunction and loss in kidney transplant recipients Data...

CDNA : 24.51 (+4.39%)
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant...

CDNA : 24.51 (+4.39%)
CareDx to Participate in Upcoming Investor Conferences

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare...

CDNA : 24.51 (+4.39%)
CareDx Announces Dismissal of 2021 Qui Tam Suit

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare...

CDNA : 24.51 (+4.39%)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CDNA : 24.51 (+4.39%)
CareDx: Q1 Earnings Snapshot

CareDx: Q1 Earnings Snapshot

CDNA : 24.51 (+4.39%)
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

Transaction extends CareDx’s Precision Medicine Testing Services strategy into specialty oncology with a Medicare-reimbursed commercial-stage MRD test and platform addressing a $4.5 Billion TAM ...

CDNA : 24.51 (+4.39%)
CareDx Announces First Quarter 2026 Financial Results

First Quarter Revenue Growth of 39% Driven by Strong Performance Across Testing Services and Patient and Digital Solutions Raises 2026 Revenue Guidance to $447 Million...

CDNA : 24.51 (+4.39%)
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting

Breadth of Data Demonstrates the Important Role of Precision Medicine Testing in Post-Transplant Monitoring and Decision Making New SHORE Data Highlights Significance...

CDNA : 24.51 (+4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 24.99
2nd Resistance Point 24.49
1st Resistance Point 23.99
Last Price 24.51
1st Support Level 22.99
2nd Support Level 22.49
3rd Support Level 21.99

See More

52-Week High 24.96
Last Price 24.51
Fibonacci 61.8% 19.61
Fibonacci 50% 17.96
Fibonacci 38.2% 16.31
52-Week Low 10.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.